Search Results - "Loftus, Elle C"

Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseases by Wilke, Matheus V M B, Klee, Eric W, Dhamija, Radhika, Fervenza, Fernando C, Thomas, Brittany, Leung, Nelson, Hogan, Marie C, Hager, Megan M, Kolbert, Kayla J, Kemppainen, Jennifer L, Loftus, Elle C, Leitzen, Katie M, Vitek, Carolyn R, McAllister, Tammy, Lazaridis, Konstantinos N, Pinto E Vairo, Filippo

“…Though next-generation sequencing (NGS) tests like exome sequencing (ES), genome sequencing (GS), and panels derived from exome and genome data (EGBP) are…”
Get full text

Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD) by Pinto E Vairo, Filippo, Kemppainen, Jennifer L, Vitek, Carolyn R Rohrer, Whalen, Denise A, Kolbert, Kayla J, Sikkink, Kaitlin J, Kroc, Sarah A, Kruisselbrink, Teresa, Shupe, Gabrielle F, Knudson, Alyssa K, Burke, Elizabeth M, Loftus, Elle C, Bandel, Lorelei A, Prochnow, Carri A, Mulvihill, Lindsay A, Thomas, Brittany, Gable, Dale M, Graddy, Courtney B, Garzon, Giovanna G Moreno, Ekpoh, Idara U, Porquera, Eva M Carmona, Fervenza, Fernando C, Hogan, Marie C, El Ters, Mireille, Warrington, Kenneth J, Davis, 3rd, John M, Koster, Matthew J, Orandi, Amir B, Basiaga, Matthew L, Vella, Adrian, Kumar, Seema, Creo, Ana L, Lteif, Aida N, Pittock, Siobhan T, Tebben, Peter J, Abate, Ejigayehu G, Joshi, Avni Y, Ristagno, Elizabeth H, Patnaik, Mrinal S, Schimmenti, Lisa A, Dhamija, Radhika, Sabrowsky, Sonia M, Wierenga, Klaas J, Keddis, Mira T, Samadder, Niloy Jewel J, Presutti, Richard J, Robinson, Steven I, Stephens, Michael C, Roberts, Lewis R, Faubion, Jr, William A, Driscoll, Sherilyn W, Wong-Kisiel, Lily C, Selcen, Duygu, Flanagan, Eoin P, Ramanan, Vijay K, Jackson, Lauren M, Mauermann, Michelle L, Ortega, Victor E, Anderson, Sarah A, Aoudia, Stacy L, Klee, Eric W, McAllister, Tammy M, Lazaridis, Konstantinos N

Get full text

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD) by Pinto E Vairo, Filippo, Kemppainen, Jennifer L, Vitek, Carolyn R Rohrer, Whalen, Denise A, Kolbert, Kayla J, Sikkink, Kaitlin J, Kroc, Sarah A, Kruisselbrink, Teresa, Shupe, Gabrielle F, Knudson, Alyssa K, Burke, Elizabeth M, Loftus, Elle C, Bandel, Lorelei A, Prochnow, Carri A, Mulvihill, Lindsay A, Thomas, Brittany, Gable, Dale M, Graddy, Courtney B, Garzon, Giovanna G Moreno, Ekpoh, Idara U, Porquera, Eva M Carmona, Fervenza, Fernando C, Hogan, Marie C, El Ters, Mireille, Warrington, Kenneth J, Davis, 3rd, John M, Koster, Matthew J, Orandi, Amir B, Basiaga, Matthew L, Vella, Adrian, Kumar, Seema, Creo, Ana L, Lteif, Aida N, Pittock, Siobhan T, Tebben, Peter J, Abate, Ejigayehu G, Joshi, Avni Y, Ristagno, Elizabeth H, Patnaik, Mrinal S, Schimmenti, Lisa A, Dhamija, Radhika, Sabrowsky, Sonia M, Wierenga, Klaas J, Keddis, Mira T, Samadder, Niloy Jewel J, Presutti, Richard J, Robinson, Steven I, Stephens, Michael C, Roberts, Lewis R, Faubion, Jr, William A, Driscoll, Sherilyn W, Wong-Kisiel, Lily C, Selcen, Duygu, Flanagan, Eoin P, Ramanan, Vijay K, Jackson, Lauren M, Mauermann, Michelle L, Ortega, Victor E, Anderson, Sarah A, Aoudia, Stacy L, Klee, Eric W, McAllister, Tammy M, Lazaridis, Konstantinos N

“…In the United States, rare disease (RD) is defined as a condition that affects fewer than 200,000 individuals. Collectively, RD affects an estimated 30 million…”
Get full text